ABOUT THIS EVENT

Scholar Rock (Nasdaq: SRRK), is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role, rings the Nasdaq Closing Bell remotely from across the country.

Tony Kingsley, President and CEO, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.